Latest current cash for NVOH: $15M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2016), NVOH shows a current cash of $15M. That compares with $18M in the prior-year period — down 15.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NVOH's current cash is now $15M (was $18M) — a 15.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged is outperforming or lagging.
Tracking NVOH's current cash over time shows whether Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $18M in the prior-year period — down 15.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $15M) with ownership activity and broader fundamentals.